🇺🇸 FDA
Patent

US 8008332

Substituted indazoles as glucokinase activators

granted A61PA61P13/12A61P15/08

Quick answer

US patent 8008332 (Substituted indazoles as glucokinase activators) held by Takeda San Diego, Inc. expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda San Diego, Inc.
Grant date
Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
49
CPC classes
A61P, A61P13/12, A61P15/08, A61P3/04, A61P3/06